- cafead   Aug 25, 2022 at 11:52: AM
via Less than a year into a strategic review, Novartis has decided on a plan for its Sandoz generics unit: a spinoff.
Novartis plans to spin Sandoz into a publicly traded, standalone business, creating Europe’s largest generics company, the Swiss drugmaker said Thursday.
article source
Novartis plans to spin Sandoz into a publicly traded, standalone business, creating Europe’s largest generics company, the Swiss drugmaker said Thursday.
article source